SCHEMBL16664982

SCHEMBL16664982

CCCNc1cc(-c2ccc(C(=O)NC)cc2)ncn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.49
CLK4 Q9HAZ1 7/20 0.49
ALDH1A1 P00352 5/20 0.49
HSD17B10 Q99714 4/20 0.49
CYP2D6 P10635 2/20 0.49
ADORA3 P0DMS8 1/20 0.46
CYP3A4 P08684 4/20 0.46
ALOX15 P16050 2/20 0.46
CYP2C19 P33261 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
USP2 O75604 2/20 0.45
ABL1 P00519 4/20 0.44
BCR P11274 4/20 0.44
PIK3CA P42336 1/20 0.44
HCAR3 P49019 1/20 0.44
CYP2C9 P11712 1/20 0.44
LCK P06239 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18902711 0.78 CYP1A2 (0.53) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6
SCHEMBL16660237 0.78 KDM4E (0.44) CYP1A2CLK4ALDH1A1HSD17B10CYP3A4
SCHEMBL16664919 0.77 PIK3CA (0.44) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6
SCHEMBL17634544 0.77 CYP1A2 (0.40) CYP1A2CLK4HSD17B10CYP2D6ADORA3
SCHEMBL16664961 0.76 FAAH (0.44) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6
SCHEMBL15473160 0.76 PTGS2 (0.53) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6
SCHEMBL19355460 0.76 CYP1A2 (0.44) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6
SCHEMBL19355310 0.76 CYP1A2 (0.59) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6
SCHEMBL19355061 0.75 CYP1A2 (0.39) CYP1A2CLK4HSD17B10CYP2D6ADORA3
SCHEMBL16664969 0.75 KDM4E (0.47) CYP1A2CLK4ALDH1A1HSD17B10CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015058031-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-04-23 WO disclosed